We focus on
KEEPING YOU UPDATED
Updates & Articles
Here you will find the latest updates from SERB and any relevant articles to our product areas.
SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines
SERB Specialty Pharmaceuticals (“SERB”), a leading European specialty pharmaceutical group focused on prescription medicines that address rare and life-threatening diseases, today announced the acquisition of BTG Specialty Pharmaceuticals, a division of Boston Scientific that develops, manufactures, and commercializes antidotes and rescue medicines to treat patients with critical conditions.Read More